閉塞デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

世界の閉塞デバイスの市場規模は、2024年～2030年の予測期間にCAGRで6.31%の成長が見込まれます。閉塞デバイスの需要は主に、さまざまな慢性疾患を患う対象患者人口の増加によって後押しされています。さらに、急速な技術開発や、低侵襲手術（MIS）需要の高まり、低侵襲手術に適した償還シナリオ、中でも老年人口の増加が、2024年～2030年の予測期間における市場全体の成長に寄与しています。

咬合器の市場力学

閉塞デバイス市場は、さまざまな要因によって製品需要が伸びており、主な要因の1つは心血管疾患の有病率の増加です。

例えば、British Heart Foundation（2023）は、2022年に世界中で約5億5,000万人が心臓および循環器の疾患とともに生活していると報告しています。さらにこの資料は、2022年、世界中で虚血性心疾患はもっとも一般的な心血管疾患の1つで2億人が罹患し、次いで末梢動脈（血管）疾患が1億1,000万人、脳卒中が1億人、心房細動が6,000万人と述べています。心血管系疾患の増加により、閉塞除去デバイスが動脈内のプラーク形成を除去して疾患を治す外科手術が増加します。

開心術よりも傷跡が残りにくく、痛みも少なく、治癒も早い低侵襲手術への需要が、閉塞デバイス市場の需要拡大につながっています。さらに、閉塞デバイスはステント留置後の手術痕や炎症などの外科手術に伴う欠点を回避するのに役立ちます。

世界保健機関（WHO）（2022）によると、2020年に世界中で約226万人が新たに乳がんと診断されました。同資料によると、2020年に世界で肺がん221万例、皮膚がん120万例、前立腺がん141万例、胃がん109万例が新たに報告されています。塞栓は、がん細胞への血流を減少させるため、手術で切除できない腫瘍を持つ一部の患者にとって安全な選択肢であることが知られています。また、化学塞栓は肝臓がんの緩和治療であり、動脈を塞いで化学療法薬を肝臓にとどまらせるのに役立ちます。このように、がんの罹患率の増加が、閉塞デバイスの需要を今後数年間に増加させる見込みです。

したがって、上記の要因が今後数年間の閉塞デバイスの需要の増加につながり、それによって予測期間（2024年～2030年）の閉塞デバイスの全体的な市場成長を引き上げます。

しかし、手術関連の合併症、厳しい規制枠組みなどが閉塞デバイス市場の成長にとっての課題となる可能性があります。

COVID-19パンデミックは閉塞デバイス市場に大きな影響を及ぼしました。その大きな理由の1つは、世界中で厳格なロックダウンが行われたことによる医療システムの再編成です。また、COVID-19患者の治療が優先されました。さまざまな慢性疾患、特に心臓弁膜症を患う患者は緊急性が低いと見なされ、治療処置の遅れにつながっています。さらに、ICUの病床不足も、閉塞デバイスの治療を含むいくつかの処置にとって現実的な課題でした。サプライチェーンの制約や熟練した専門家の不足に加え、デバイスの流通にも限界があり、このことは結果として閉塞デバイスの需要に影響を与えました。しかし、ロックダウン解除後の活動再開とワクチン投与により、患者はがんや心血管疾患を含むさまざまな慢性疾患の治療に病院や診療所を訪れるようになり、閉塞デバイスの需要の増加につながったため、閉塞デバイス市場は軌道に乗っています。

咬合器市場のセグメント分析

閉塞デバイス市場の用途セグメントでは、神経カテゴリが2023年に大きな収益シェアを獲得する見込みです。

脳動脈瘤の有病率の上昇と先進技術を利用した新製品の発売が、市場全体の成長を促進すると予測されています。

例えば、Brain Aneurysm Foundationが行った2021年の推計によると、米国では毎年約3万人が脳動脈瘤の破裂に苦しんでいます。

同資料は、特に55歳以上の女性は男性よりも脳動脈瘤破裂のリスクが高いと述べています。このリスクは老年人口が増加するにつれて将来増加すると予測されます。

当レポートでは、世界の閉塞デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 閉塞デバイス市場レポートのイントロダクション

第2章 閉塞デバイス市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 閉塞デバイス市場の主な要因の分析

• 閉塞デバイス市場の促進要因
• 閉塞デバイス市場の抑制要因と課題
• 閉塞デバイス市場の機会

第5章 閉塞デバイス市場のポーターのファイブフォース分析

第6章 閉塞デバイス市場のレイアウト

• 製品タイプ
  • 塞栓デバイス
  • 閉塞除去デバイス
  • 支援デバイス
• 用途別
  • 腫瘍
  • 心臓
  • 神経
  • その他
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域
  • 北米の閉塞デバイスの市場規模（2021年～2030年）
  • 欧州の閉塞デバイスの市場規模（2021年～2030年）
  • アジア太平洋の閉塞デバイスの市場規模（2021年～2030年）
  • その他の地域の閉塞デバイスの市場規模（2021年～2030年）

第7章 閉塞デバイス市場の企業と製品のプロファイル

• Abbott
• Acrostak Int.
• Terumo Corporation
• Edwards Lifesciences Corporation
• Cordis
• B. Braun SE
• Cook
• Medtronic
• Cardinal Health
• AngioDynamics
• Integer Holdings Corporation
• Acandis GmbH
• Penumbra, Inc.
• LeMaitre Vascular Inc.
• Lepu Medical
• Stryker
• Boston Scientific Corporation
• Artio Medical Inc.
• KYOTO MEDICAL PLANNING Co., Ltd.
• Kaneka Medix Corporation

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Occlusion Devices Market in Global (2021-2030)
• Table 3: Occlusion Devices Market in Global by Product Type (2021-2030)
• Table 4: Occlusion Devices Market in Global by Application (2021-2030)
• Table 5: Occlusion Devices Market in Global by End-User (2021-2030)
• Table 6: Occlusion Devices Market in Global by Geography (2021-2030)
• Table 7: Occlusion Devices Market in North America (2021-2030)
• Table 8: Occlusion Devices Market in North America by Country (2021-2030)
• Table 9: Occlusion Devices Market in the US (2021-2030)
• Table 10: Occlusion Devices Market in Canada (2021-2030)
• Table 11: Occlusion Devices Market in Mexico (2021-2030)
• Table 12: Occlusion Devices Market in Europe (2021-2030)
• Table 13: Occlusion Devices Market in Europe by Country (2021-2030)
• Table 14: Occlusion Devices Market in France (2021-2030)
• Table 15: Occlusion Devices Market in Germany (2021-2030)
• Table 16: Occlusion Devices Market in the United Kingdom (2021-2030)
• Table 17: Occlusion Devices Market in Italy (2021-2030)
• Table 18: Occlusion Devices Market in Spain (2021-2030)
• Table 19: Occlusion Devices Market in the Rest of Europe (2021-2030)
• Table 20: Occlusion Devices Market in Asia-Pacific (2021-2030)
• Table 21: Occlusion Devices Market in Asia-Pacific by Country (2021-2030)
• Table 22: Occlusion Devices Market in China (2021-2030)
• Table 23: Occlusion Devices Market in Japan (2021-2030)
• Table 24: Occlusion Devices Market in India (2021-2030)
• Table 25: Occlusion Devices Market in Australia (2021-2030)
• Table 26: Occlusion Devices Market in South Korea (2021-2030)
• Table 27: Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 28: Occlusion Devices Market in the Rest of the World (2021-2030)
• Table 29: Occlusion Devices Market in RoW by Region (2021-2030)
• Table 30: Occlusion Devices Market in the Middle East (2021-2030)
• Table 31: Occlusion Devices Market in Africa (2021-2030)
• Table 32: Occlusion Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Occlusion Devices Market in Global (2021-2030)
• Figure 3: Occlusion Devices Market in Global by Product Type (2021-2030)
• Figure 4: Occlusion Devices Market in Global by Application (2021-2030)
• Figure 5: Occlusion Devices Market in Global by End-User (2021-2030)
• Figure 6: Occlusion Devices Market in Global by Geography (2021-2030)
• Figure 7: Occlusion Devices Market in North America (2021-2030)
• Figure 8: Occlusion Devices Market in North America by Country (2021-2030)
• Figure 9: Occlusion Devices Market in the US (2021-2030)
• Figure 10: Occlusion Devices Market in Canada (2021-2030)
• Figure 11: Occlusion Devices Market in Mexico (2021-2030)
• Figure 12: Occlusion Devices Market in Europe (2021-2030)
• Figure 13: Occlusion Devices Market in Europe by Country (2021-2030)
• Figure 14: Occlusion Devices Market in France (2021-2030)
• Figure 15: Occlusion Devices Market in Germany (2021-2030)
• Figure 16: Occlusion Devices Market in the United Kingdom (2021-2030)
• Figure 17: Occlusion Devices Market in Italy (2021-2030)
• Figure 18: Occlusion Devices Market in Spain (2021-2030)
• Figure 19: Occlusion Devices Market in the Rest of Europe (2021-2030)
• Figure 20: Occlusion Devices Market in Asia-Pacific (2021-2030)
• Figure 21: Occlusion Devices Market in Asia-Pacific by Country (2021-2030)
• Figure 22: Occlusion Devices Market in China (2021-2030)
• Figure 23: Occlusion Devices Market in Japan (2021-2030)
• Figure 24: Occlusion Devices Market in India (2021-2030)
• Figure 25: Occlusion Devices Market in Australia (2021-2030)
• Figure 26: Occlusion Devices Market in South Korea (2021-2030)
• Figure 27: Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 28: Occlusion Devices Market in the Rest of the World (2021-2030)
• Figure 29: Occlusion Devices Market in RoW by Region (2021-2030)
• Figure 30: Occlusion Devices Market in the Middle East (2021-2030)
• Figure 31: Occlusion Devices Market in Africa (2021-2030)
• Figure 32: Occlusion Devices Market in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Marker Opportunities
• Figure 36: PORTER'S Five Force Analysis

Occlusion Devices Market By Product Type (Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, And Others], And Support Devices), By Application (Oncology, Cardiology, Neurology, And Others), By End-User (Hospitals, Ambulatory Surgical Centres, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular diseases, cancers, and other chronic diseases and the rising technological advancements in the occlusion devices

The global occlusion devices market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030. The demand for occlusion devices is primarily being boosted by the increasing number of target patient populations suffering from various chronic illnesses. Furthermore, surging technological developments, rising demand for minimally invasive surgeries (MIS), suitable reimbursement scenarios for minimally invasive surgeries, and an increasing geriatric population among others have contributed to the overall growth of the occlusion devices market during the forecast period from 2024-2030.

Occlusion Devices Market Dynamics:

The occlusion devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of cardiovascular diseases.

For instance, British Heart Foundation (2023) reported that around 550 million people were living with heart and circulatory diseases in 2022, across the world. Further, the source stated that ischemic heart disease is one of the most common cardiovascular disorders, affecting 200 million people, followed by peripheral arterial (vascular) disease with 110 million people, stroke with 100 million people, and atrial fibrillation affecting 60 million people in 2022, globally. The increasing number of cardiovascular diseases will in turn increase the number of surgical procedures in which the occlusion removal devices will aid by removing the plaque formation in the arteries, thereby curing the ailment.

The demand for minimally invasive surgeries that offer less scarring reduced pain, and faster healing than open-heart surgeries has led to the growth of demand for occlusion devices in the market. Furthermore, occlusion devices help in avoiding disadvantages associated with surgical procedures such as surgical scarring and inflammation after stent implantation.

According to the World Health Organization (WHO) 2022, it was stated that approximately 2.26 million new instances of breast cancer were diagnosed worldwide, in 2020. According to the same source, 2.21 million new cases of lung cancer, 1.20 million cases of skin cancer, 1.41 million cases of prostate cancer, and 1.09 million cases of stomach cancer were reported worldwide, in 2020. Embolization is known to be a safe option for some patients with tumors that cannot be removed by surgery as these devices reduce the blood flow to cancer cells. Also, chemoembolization is a palliative treatment for liver cancer that helps in blocking the artery to let the chemotherapy drug stay in the liver. Thus, the increasing incidence of cancer will increase the demand for occlusion devices in the upcoming years.

Therefore, the factors mentioned above will lead to an increased demand for occlusion devices in the upcoming years, thereby raising the overall market growth for occlusion devices during the forecast period (2024-2030).

However, surgery-related complications, stringent regulatory framework, and others can impose a challenge to occlusion device market growth.

The COVID-19 pandemic had significantly impacted the occlusion devices market one of the major reasons being the reorganization of healthcare systems owing to strict lockdown imposition across the globe. Also, the treatment of patients suffering from covid-19 infection was a priority. Patients suffering from various chronic diseases, particularly those with heart valve diseases were considered non-urgent which led to delays in their treatment procedures. Further, the shortage of ICU beds also possessed a real challenge for several procedures involving occlusion device treatments. Along with the restriction in the supply chain and shortage of skilled professionals, there was a limit in the distribution of devices which ultimately affected the demand for occlusion devices. However, with the resumption of activities after the relaxation of the lockdown and with the vaccine administration, the patients started visiting hospitals and clinics for the treatment of various chronic diseases including cancer and cardiovascular diseases, leading to an increased demand for occlusion devices, thereby bring the market of occlusion devices on track.

Occlusion Devices Market Segment Analysis:

Occlusion Devices Market by Product Type (Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, and Others], and Support Devices), Application (Oncology, Cardiology, Vascular Diseases, Neurology, and Others), End-User (Hospitals, Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the occlusion devices market, the neurology category is expected to amass a significant revenue share in the year 2023.

The rising prevalence of brain aneurysms and the launch of new technologically advanced products are expected to drive the overall growth of the market.

For instance, according to 2021 estimations done by the Brain Aneurysm Foundation, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year.

The same source stated that women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population increases.

Further, blood artery damage or trauma, smoking, hypertension, and genetic susceptibility are all risk factors for the development of a brain aneurysm. Medical therapy, surgical clipping, endovascular therapy, or coiling without or with adjunctive devices are among the options for treating brain aneurysms. For instance, according to the WHO key statistics from August 2021, there were an estimated 1.28 billion adults worldwide, aged 30-79, who had hypertension, with the majority of them (two-thirds) residing in low- and middle-income countries. The increasing statistics of hypertension will increase the number of patients suffering from cardiovascular diseases, ultimately increasing the demand for occlusion devices used in the treatment of cardiovascular diseases.

Hence, owing to all the aforementioned factors, the market will experience an increased demand for neurology occlusion devices, thus growing the occlusion devices market during the forecast period.

North America is expected to dominate the overall Occlusion Devices Market:

Among all the regions, North America is estimated to account for the largest share of the occlusion devices market in the year 2023. Owing to key growth factors such as the rising prevalence of cardiovascular diseases, increasing cases of cancer, as well as neurological conditions like brain aneurysms, along with the soaring advancement in devices, and newer government initiatives regarding disease treatment awareness, are driving the North America occlusion devices market.

For instance, the Centers for Disease Control and Prevention (CDC) 2022, reported that every year, about 805,000 people in the United States suffer from heart attacks, especially among most racial and ethnic groups in the United States. As per, CDC 2021, about 18.2 million adults of age 20 years and older had coronary artery disease, and about 360,900 people died in 2019 due to coronary heart disease. As a result, more operations are anticipated due to the high mortality rate from cardiovascular diseases in the nation. This will likely lead to a rise in the usage of occlusion devices and support the expansion of the market.

Moreover, the rising prevalence of cancer in the US is also considered a key factor in the growing demand for occlusion devices.

In 2023, the American Cancer Society reported that in the United States 2023, nearly 1,958,310 new cancer cases are projected to occur. The increasing incidence of cancer is expected to drive the demand for interventional procedures in the region, thereby increasing the demand for occlusion devices as these devices work by stopping the blood flow toward tumors.

Therefore, the presence of a massive patient population suffering from various diseases correlates with an increase in product demand which supports the growth of the United States occlusion devices market as well as the overall North America occlusion devices market during the forecast period from 2024-2030.

Hence, the above-mentioned factors are going to generate considerable revenue thereby pushing the overall growth of the occlusion devices market in the North America region during the forecast period.

Occlusion Devices Market Key Players:

Some of the key market players operating in the occlusion devices market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

Recent Developmental Activities in the Occlusion Devices Market:

In February 2022, Front Line Medical Technologies announced the availability and distribution of COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) which is strong enough to hold back aortic pressure and allows for permissive hypotension in bleeding areas below the balloon, thus decreasing chances of hemorrhage. It is the smallest life-saving bleeding control device.

In July 2021, Terumo Medical Corporation (TMC) announced the introduction of its AZUR Vascular Plug, the only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter.

In September 2020, Boston Scientific Corporation received U.S. Food & Drug Administration (FDA) approval to launch WATCHMAN FLX, which is a Left Atrial Appendage Closure (LAAC) device. It is designed to seal off Heart's left atrial appendage to prevent blood clot formation.

Key Takeaways from the Occlusion Devices Market Report Study

Market size analysis for current occlusion devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global occlusion devices market.

Various opportunities available for the other competitor in the occlusion devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current occlusion devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for occlusion devices market growth in the coming future?

Target Audience who can be benefited from this Occlusion Devices Market Report Study

Occlusion devices products providers

Research organizations and consulting companies

Occlusion devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in occlusion devices

Various End-users who want to know more about the occlusion devices market and the latest technological developments in the occlusion devices market.

Frequently Asked Questions for the Occlusion Devices Market:

1. What is an occlusion device?

Occlusion devices are used to create occlusion in the vessels to stop the blood flow.

2. What is the market for global occlusion devices?

The global occlusion devices market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030.

3. What are the drivers for global occlusion devices market?

The demand for occlusion devices is primarily being boosted by the rising prevalence of cardiovascular diseases, cancers, and other chronic diseases. Further, the rising adoption of minimally invasive devices, increasing geriatric population base, innovations in product development, and others will increase the demand for the overall growth of the occlusion devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global occlusion devices market?

Some of the key market players operating in the occlusion devices market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

5. Which region has the highest share in the occlusion devices market?

North America is expected to dominate the overall occlusion devices market during the forecast period, 2024 to 2030. Factors such as the rising prevalence of cardiovascular diseases, cancers, and other chronic diseases, the rising geriatric population, and better healthcare infrastructure have had an immense effect on the growth of occlusion devices in the North America market. Furthermore, the rise in research to validate the efficacy of occlusion devices and the growing preference for minimally invasive devices also helped the market growth in this region.

Table of Contents

1.Occlusion Devices Market Report Introduction

2. Occlusion Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Occlusion Devices Market Key Factors Analysis

• 4.1. Occlusion Devices Market Drivers
  • 4.1.1. Rising number of surgical procedures owing to the increasing number of chronic diseases
  • 4.1.2. Increasing preference for minimally invasive surgery
  • 4.1.3. Technological advancements in product development
• 4.2. Occlusion Devices Market Restraints and Challenges
  • 4.2.1. Surgery-Related Complications
  • 4.2.2. Stringent regulatory framework
• 4.3. Occlusion Devices Market Opportunities
  • 4.3.1. Advancements in the materials and configurations of occlusion devices

5. Occlusion Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Occlusion Devices Market Layout

• 6.1. By Product Type
  • 6.1.1. Embolization Devices
  • 6.1.2. Occlusion Removal Devices
    • 6.1.2.1. Coil Retrievers
    • 6.1.2.2. Stent Retrievers
    • 6.1.2.3. Others
  • 6.1.3. Support Devices
• 6.2. By Application
  • 6.2.1. Oncology
  • 6.2.2. Cardiology
  • 6.2.3. Neurology
  • 6.2.4. Others
• 6.3. By End-User
  • 6.3.1. Hospitals
  • 6.3.2. Ambulatory Surgical Centers
  • 6.3.3. Others
• 6.4. By Geography
  • 6.4.1. North America Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.1.1. United States Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.1.2. Canada Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.1.3. Mexico Occlusion Devices Market Size in USD million (2021-2030)
  • 6.4.2. Europe Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2.1. France Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2.2. Germany Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2.3. United Kingdom Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2.4. Italy Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2.5. Spain Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Occlusion Devices Market Size in USD million (2021-2030)
  • 6.4.3. Asia-Pacific Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3.1. China Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3.2. Japan Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3.3. India Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3.4. Australia Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3.5. South Korea Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3.6. Rest of the Asia-Pacific Occlusion Devices Market Size in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW) Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4.1. Middle East Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4.2. Africa Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4.3. South America Occlusion Devices Market Size in USD million (2021-2030)

7. Occlusion Devices Market Company and Product Profiles

• 7.1.1. Abbott
  • 7.1.1.1. Company Overview
  • 7.1.1.2. Company Snapshot
  • 7.1.1.3. Financial Overview
  • 7.1.1.4. Product Listing
  • 7.1.1.5. Entropy
• 7.1.2. Acrostak Int.
  • 7.1.2.1. Company Overview
  • 7.1.2.2. Company Snapshot
  • 7.1.2.3. Financial Overview
  • 7.1.2.4. Product Listing
  • 7.1.2.5. Entropy
• 7.1.3. Terumo Corporation
  • 7.1.3.1. Company Overview
  • 7.1.3.2. Company Snapshot
  • 7.1.3.3. Financial Overview
  • 7.1.3.4. Product Listing
  • 7.1.3.5. Entropy
• 7.1.4. Edwards Lifesciences Corporation
  • 7.1.4.1. Company Overview
  • 7.1.4.2. Company Snapshot
  • 7.1.4.3. Financial Overview
  • 7.1.4.4. Product Listing
  • 7.1.4.5. Entropy
• 7.1.5. Cordis
  • 7.1.5.1. Company Overview
  • 7.1.5.2. Company Snapshot
  • 7.1.5.3. Financial Overview
  • 7.1.5.4. Product Listing
  • 7.1.5.5. Entropy
• 7.1.6. B. Braun SE
  • 7.1.6.1. Company Overview
  • 7.1.6.2. Company Snapshot
  • 7.1.6.3. Financial Overview
  • 7.1.6.4. Product Listing
  • 7.1.6.5. Entropy
• 7.1.7. Cook
  • 7.1.7.1. Company Overview
  • 7.1.7.2. Company Snapshot
  • 7.1.7.3. Financial Overview
  • 7.1.7.4. Product Listing
  • 7.1.7.5. Entropy
• 7.1.8. Medtronic
  • 7.1.8.1. Company Overview
  • 7.1.8.2. Company Snapshot
  • 7.1.8.3. Financial Overview
  • 7.1.8.4. Product Listing
  • 7.1.8.5. Entropy
• 7.1.9. Cardinal Health
  • 7.1.9.1. Company Overview
  • 7.1.9.2. Company Snapshot
  • 7.1.9.3. Financial Overview
  • 7.1.9.4. Product Listing
  • 7.1.9.5. Entropy
• 7.1.10. AngioDynamics
  • 7.1.10.1. Company Overview
  • 7.1.10.2. Company Snapshot
  • 7.1.10.3. Financial Overview
  • 7.1.10.4. Product Listing
  • 7.1.10.5. Entropy
• 7.1.11. Integer Holdings Corporation
  • 7.1.11.1. Company Overview
  • 7.1.11.2. Company Snapshot
  • 7.1.11.3. Financial Overview
  • 7.1.11.4. Product Listing
  • 7.1.11.5. Entropy
• 7.1.12. Acandis GmbH
  • 7.1.12.1. Company Overview
  • 7.1.12.2. Company Snapshot
  • 7.1.12.3. Financial Overview
  • 7.1.12.4. Product Listing
  • 7.1.12.5. Entropy
• 7.1.13. Penumbra, Inc.
  • 7.1.13.1. Company Overview
  • 7.1.13.2. Company Snapshot
  • 7.1.13.3. Financial Overview
  • 7.1.13.4. Product Listing
  • 7.1.13.5. Entropy
• 7.1.14. LeMaitre Vascular Inc.
  • 7.1.14.1. Company Overview
  • 7.1.14.2. Company Snapshot
  • 7.1.14.3. Financial Overview
  • 7.1.14.4. Product Listing
  • 7.1.14.5. Entropy
• 7.1.15. Lepu Medical
  • 7.1.15.1. Company Overview
  • 7.1.15.2. Company Snapshot
  • 7.1.15.3. Financial Overview
  • 7.1.15.4. Product Listing
  • 7.1.15.5. Entropy
• 7.1.16. Stryker
  • 7.1.16.1. Company Overview
  • 7.1.16.2. Company Snapshot
  • 7.1.16.3. Financial Overview
  • 7.1.16.4. Product Listing
  • 7.1.16.5. Entropy
• 7.1.17. Boston Scientific Corporation
  • 7.1.17.1. Company Overview
  • 7.1.17.2. Company Snapshot
  • 7.1.17.3. Financial Overview
  • 7.1.17.4. Product Listing
  • 7.1.17.5. Entropy
• 7.1.18. Artio Medical Inc.
  • 7.1.18.1. Company Overview
  • 7.1.18.2. Company Snapshot
  • 7.1.18.3. Financial Overview
  • 7.1.18.4. Product Listing
  • 7.1.18.5. Entropy
• 7.1.19. KYOTO MEDICAL PLANNING Co., Ltd.
  • 7.1.19.1. Company Overview
  • 7.1.19.2. Company Snapshot
  • 7.1.19.3. Financial Overview
  • 7.1.19.4. Product Listing
  • 7.1.19.5. Entropy
• 7.1.20. Kaneka Medix Corporation
  • 7.1.20.1. Company Overview
  • 7.1.20.2. Company Snapshot
  • 7.1.20.3. Financial Overview
  • 7.1.20.4. Product Listing
  • 7.1.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us